Literature DB >> 12616691

Metabolic engineering of Escherichia coli: increase of NADH availability by overexpressing an NAD(+)-dependent formate dehydrogenase.

Susana J Berríos-Rivera1, George N Bennett, Ka-Yiu San.   

Abstract

Metabolic engineering studies have generally focused on manipulating enzyme levels through either the amplification, addition, or deletion of a particular pathway. However, with cofactor-dependent production systems, once the enzyme levels are no longer limiting, cofactor availability and the ratio of the reduced to oxidized form of the cofactor can become limiting. Under these situations, cofactor manipulation may become crucial in order to further increase system productivity. Although it is generally known that cofactors play a major role in the production of different fermentation products, their role has not been thoroughly and systematically studied. However, cofactor manipulations can potentially become a powerful tool for metabolic engineering. Nicotinamide adenine dinucleotide (NAD) functions as a cofactor in over 300 oxidation-reduction reactions and regulates various enzymes and genetic processes. The NADH/NAD+ cofactor pair plays a major role in microbial catabolism, in which a carbon source, such as glucose, is oxidized using NAD+ producing reducing equivalents in the form of NADH. It is crucially important for continued cell growth that NADH be oxidized to NAD+ and a redox balance be achieved. Under aerobic growth, oxygen is used as the final electron acceptor. While under anaerobic growth, and in the absence of an alternate oxidizing agent, the regeneration of NAD+ is achieved through fermentation by using NADH to reduce metabolic intermediates. Therefore, an increase in the availability of NADH is expected to have an effect on the metabolic distribution. This paper investigates a genetic means of manipulating the availability of intracellular NADH in vivo by regenerating NADH through the heterologous expression of an NAD(+)-dependent formate dehydrogenase. More specifically, it explores the effect on the metabolic patterns in Escherichia coli under anaerobic and aerobic conditions of substituting the native cofactor-independent formate dehydrogenase (FDH) by and NAD(+)-dependent FDH from Candida boidinii. The over-expression of the NAD(+)-dependent FDH doubled the maximum yield of NADH from 2 to 4 mol NADH/mol glucose consumed, increased the final cell density, and provoked a significant change in the final metabolite concentration pattern both anaerobically and aerobically. Under anaerobic conditions, the production of more reduced metabolites was favored, as evidenced by a dramatic increase in the ethanol-to-acetate ratio. Even more interesting is the observation that during aerobic growth, the increased availability of NADH induced a shift to fermentation even in the presence of oxygen by stimulating pathways that are normally inactive under these conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12616691     DOI: 10.1006/mben.2002.0227

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  59 in total

1.  Manipulating respiratory levels in Escherichia coli for aerobic formation of reduced chemical products.

Authors:  Jiangfeng Zhu; Ailen Sánchez; George N Bennett; Ka-Yiu San
Journal:  Metab Eng       Date:  2011-10-06       Impact factor: 9.783

2.  Metabolic and transcriptional response to cofactor perturbations in Escherichia coli.

Authors:  Anders K Holm; Lars M Blank; Marco Oldiges; Andreas Schmid; Christian Solem; Peter R Jensen; Goutham N Vemuri
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

3.  Increasing reducing power output (NADH) of glucose catabolism for reduction of xylose to xylitol by genetically engineered Escherichia coli AI05.

Authors:  Andrew Iverson; Erin Garza; Jinfang Zhao; Yongze Wang; Xiao Zhao; Jinhua Wang; Ryan Manow; Shengde Zhou
Journal:  World J Microbiol Biotechnol       Date:  2013-02-23       Impact factor: 3.312

4.  Controlled biosynthesis of odd-chain fuels and chemicals via engineered modular metabolic pathways.

Authors:  Hsien-Chung Tseng; Kristala L J Prather
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

5.  Ferrous-Iron-Activated Transcriptional Factor AdhR Regulates Redox Homeostasis in Clostridium beijerinckii.

Authors:  Bin Yang; Xiaoqun Nie; Youli Xiao; Yang Gu; Weihong Jiang; Chen Yang
Journal:  Appl Environ Microbiol       Date:  2020-03-18       Impact factor: 4.792

6.  Engineering microaerobic metabolism of E. coli for 1,2-propanediol production.

Authors:  Rachit Jain; Jin Huang; Qipeng Yuan; Yajun Yan
Journal:  J Ind Microbiol Biotechnol       Date:  2015-05-07       Impact factor: 3.346

7.  Microbial Cell Factories à la Carte: Elimination of Global Regulators Cra and ArcA Generates Metabolic Backgrounds Suitable for the Synthesis of Bioproducts in Escherichia coli.

Authors:  Diego E Egoburo; Rocío Diaz Peña; Daniela S Alvarez; Manuel S Godoy; Mariela P Mezzina; M Julia Pettinari
Journal:  Appl Environ Microbiol       Date:  2018-09-17       Impact factor: 4.792

8.  Systems Analysis of NADH Dehydrogenase Mutants Reveals Flexibility and Limits of Pseudomonas taiwanensis VLB120's Metabolism.

Authors:  Salome C Nies; Robert Dinger; Yan Chen; Gossa G Wordofa; Mette Kristensen; Konstantin Schneider; Jochen Büchs; Christopher J Petzold; Jay D Keasling; Lars M Blank; Birgitta E Ebert
Journal:  Appl Environ Microbiol       Date:  2020-05-19       Impact factor: 4.792

9.  Improvement of butanol production in Clostridium acetobutylicum through enhancement of NAD(P)H availability.

Authors:  Feng Qi; Chandresh Thakker; Fayin Zhu; Matthew Pena; Ka-Yiu San; George N Bennett
Journal:  J Ind Microbiol Biotechnol       Date:  2018-08-23       Impact factor: 3.346

Review 10.  Minimizing acetate formation in E. coli fermentations.

Authors:  Marjan De Mey; Sofie De Maeseneire; Wim Soetaert; Erick Vandamme
Journal:  J Ind Microbiol Biotechnol       Date:  2007-08-01       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.